TBK1 and systemic lupus erythematosus: Moreover, inactivation of USP8 significantly decreases the protein levels of MDA5 and p‐TBK1 in PBMCs isolated from DM/SLE patients, suggesting the potential of USP8 inhibitors for the treatment of these diseases.